nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB2—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB2—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MBD2—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NOS2—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—IL6—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—KRAS—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB2—bile duct cancer	0.00123	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—IL6—bile duct cancer	0.00123	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—IL6—bile duct cancer	0.00123	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB2—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB2—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TGFB1—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—HRAS—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—HRAS—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—HRAS—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—HRAS—bile duct cancer	0.00118	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—G Protein Signaling Pathways—HRAS—bile duct cancer	0.00116	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—IL6—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—IL6—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—KRAS—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—IL6—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—NRAS—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.00113	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—IL6—bile duct cancer	0.00113	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—bile duct cancer	0.00113	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NRAS—bile duct cancer	0.00112	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB2—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—NRAS—bile duct cancer	0.00109	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—KRAS—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNAS—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RNF43—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—HRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP2—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—NRAS—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—NRAS—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—NRAS—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—NRAS—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—bile duct cancer	0.001	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.000992	0.000992	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—bile duct cancer	0.000991	0.000991	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000988	0.000988	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000984	0.000984	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—HRAS—bile duct cancer	0.000978	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—GNAS—bile duct cancer	0.000978	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—KRAS—bile duct cancer	0.000978	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNAS—bile duct cancer	0.000978	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—KRAS—bile duct cancer	0.000967	0.000967	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—NRAS—bile duct cancer	0.000947	0.000947	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—NRAS—bile duct cancer	0.000947	0.000947	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—NRAS—bile duct cancer	0.000939	0.000939	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—bile duct cancer	0.000937	0.000937	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—KRAS—bile duct cancer	0.000936	0.000936	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HGF—bile duct cancer	0.000932	0.000932	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—bile duct cancer	0.000931	0.000931	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.00093	0.00093	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—bile duct cancer	0.000926	0.000926	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.000926	0.000926	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—NRAS—bile duct cancer	0.000926	0.000926	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IDH1—bile duct cancer	0.000924	0.000924	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—bile duct cancer	0.000922	0.000922	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—bile duct cancer	0.000917	0.000917	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—bile duct cancer	0.000917	0.000917	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—HRAS—bile duct cancer	0.000915	0.000915	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—IDH2—bile duct cancer	0.0009	0.0009	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—KRAS—bile duct cancer	0.00088	0.00088	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—KRAS—bile duct cancer	0.000875	0.000875	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.000875	0.000875	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SMAD4—bile duct cancer	0.000872	0.000872	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—KRAS—bile duct cancer	0.000871	0.000871	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—KRAS—bile duct cancer	0.000867	0.000867	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—bile duct cancer	0.000863	0.000863	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—bile duct cancer	0.000863	0.000863	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—bile duct cancer	0.000855	0.000855	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFBR2—bile duct cancer	0.000855	0.000855	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HGF—bile duct cancer	0.000851	0.000851	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—bile duct cancer	0.000848	0.000848	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.000848	0.000848	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—bile duct cancer	0.000844	0.000844	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—bile duct cancer	0.000842	0.000842	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.000839	0.000839	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.000836	0.000836	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—bile duct cancer	0.000836	0.000836	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—HRAS—bile duct cancer	0.000831	0.000831	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000828	0.000828	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—HRAS—bile duct cancer	0.000822	0.000822	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—KRAS—bile duct cancer	0.000815	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—KRAS—bile duct cancer	0.000815	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000812	0.000812	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.000811	0.000811	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SMAD4—bile duct cancer	0.000809	0.000809	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—KRAS—bile duct cancer	0.000808	0.000808	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.000801	0.000801	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.0008	0.0008	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KRAS—bile duct cancer	0.000797	0.000797	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—bile duct cancer	0.000796	0.000796	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—bile duct cancer	0.000795	0.000795	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—bile duct cancer	0.000787	0.000787	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP9—bile duct cancer	0.000776	0.000776	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—IDH1—bile duct cancer	0.000774	0.000774	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000767	0.000767	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.000764	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—bile duct cancer	0.000761	0.000761	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RNF43—bile duct cancer	0.000752	0.000752	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—bile duct cancer	0.000751	0.000751	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—bile duct cancer	0.000748	0.000748	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—bile duct cancer	0.000744	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	0.000744	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—bile duct cancer	0.00074	0.00074	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.000739	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—bile duct cancer	0.000738	0.000738	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000737	0.000737	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—bile duct cancer	0.000737	0.000737	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.000722	0.000722	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—bile duct cancer	0.000716	0.000716	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS2—bile duct cancer	0.000715	0.000715	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—bile duct cancer	0.000712	0.000712	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NRAS—bile duct cancer	0.000712	0.000712	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—bile duct cancer	0.000708	0.000708	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—bile duct cancer	0.000705	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.000698	0.000698	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—bile duct cancer	0.000693	0.000693	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—bile duct cancer	0.000693	0.000693	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—bile duct cancer	0.000687	0.000687	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000682	0.000682	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.000681	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—bile duct cancer	0.000678	0.000678	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—bile duct cancer	0.000663	0.000663	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—bile duct cancer	0.000663	0.000663	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TGFB1—bile duct cancer	0.000661	0.000661	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—bile duct cancer	0.000657	0.000657	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.000652	0.000652	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—bile duct cancer	0.000649	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NRAS—bile duct cancer	0.000645	0.000645	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NRAS—bile duct cancer	0.000641	0.000641	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TGFB1—bile duct cancer	0.000639	0.000639	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000628	0.000628	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNAS—bile duct cancer	0.000618	0.000618	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000614	0.000614	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—KRAS—bile duct cancer	0.000613	0.000613	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—bile duct cancer	0.000602	0.000602	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFBR2—bile duct cancer	0.000599	0.000599	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000593	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—bile duct cancer	0.000588	0.000588	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000587	0.000587	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—bile duct cancer	0.000584	0.000584	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNAS—bile duct cancer	0.000578	0.000578	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000568	0.000568	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMAD4—bile duct cancer	0.000567	0.000567	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNAS—bile duct cancer	0.000561	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KRAS—bile duct cancer	0.000555	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KRAS—bile duct cancer	0.000552	0.000552	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—bile duct cancer	0.000545	0.000545	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—bile duct cancer	0.000521	0.000521	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC5A5—bile duct cancer	0.000511	0.000511	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SMAD4—bile duct cancer	0.000501	0.000501	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFBR2—bile duct cancer	0.000491	0.000491	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—bile duct cancer	0.000491	0.000491	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HGF—bile duct cancer	0.000489	0.000489	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—bile duct cancer	0.000484	0.000484	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—bile duct cancer	0.000482	0.000482	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—bile duct cancer	0.000472	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—bile duct cancer	0.000469	0.000469	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SMAD4—bile duct cancer	0.000465	0.000465	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—bile duct cancer	0.000453	0.000453	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—bile duct cancer	0.000452	0.000452	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—bile duct cancer	0.000449	0.000449	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—bile duct cancer	0.000443	0.000443	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—bile duct cancer	0.000409	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—bile duct cancer	0.000409	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAS—bile duct cancer	0.000397	0.000397	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—bile duct cancer	0.00038	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—bile duct cancer	0.000373	0.000373	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—bile duct cancer	0.000372	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—bile duct cancer	0.000368	0.000368	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—bile duct cancer	0.000352	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—bile duct cancer	0.000352	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—bile duct cancer	0.000346	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—bile duct cancer	0.000345	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFBR2—bile duct cancer	0.000344	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—bile duct cancer	0.00034	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—bile duct cancer	0.000335	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAS—bile duct cancer	0.000332	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMAD4—bile duct cancer	0.000325	0.000325	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—bile duct cancer	0.00032	0.00032	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—bile duct cancer	0.000317	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—bile duct cancer	0.000317	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—bile duct cancer	0.000314	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—bile duct cancer	0.000313	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—bile duct cancer	0.000297	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—bile duct cancer	0.000295	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—bile duct cancer	0.000286	0.000286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—bile duct cancer	0.000282	0.000282	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—bile duct cancer	0.000273	0.000273	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—bile duct cancer	0.000272	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—bile duct cancer	0.000269	0.000269	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—bile duct cancer	0.000261	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—bile duct cancer	0.000258	0.000258	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—bile duct cancer	0.000254	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—bile duct cancer	0.000252	0.000252	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—bile duct cancer	0.000241	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—bile duct cancer	0.000241	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—bile duct cancer	0.000224	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—bile duct cancer	0.00022	0.00022	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—bile duct cancer	0.000213	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—bile duct cancer	0.000208	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—bile duct cancer	0.000202	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—bile duct cancer	0.000198	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—bile duct cancer	0.000195	0.000195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—bile duct cancer	0.000184	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—bile duct cancer	0.000182	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—bile duct cancer	0.000169	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—bile duct cancer	0.000156	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—bile duct cancer	0.00015	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—bile duct cancer	0.000119	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—bile duct cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—bile duct cancer	0.000101	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—bile duct cancer	9.7e-05	9.7e-05	CbGpPWpGaD
